Wakefield, Massachusetts – September 13, 2019 – Today Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading vertically integrated cannabis operator in the United States, was granted approval for its three final and two provisional adult-use licenses by the Massachusetts Cannabis Control Commission.
Following today's approval of all five licenses, the next step in the process is to schedule post-final inspections for the three final licenses before the Commission issues their notice to commence operations. The process is expected to be completed in the coming months.
"We appreciate the work of the Cannabis Control Commission and the Commission staff and will continue to work collaboratively with them to move forward in securing approval on our final inspections," said Joseph Lusardi, CEO of Curaleaf. "We have been proudly serving this community for two years as a medical company and are excited about this important step in the process toward receiving our adult-use licenses."
The three final adult-use licenses are: a retail license to be co-located with the current medical retail location in Oxford, and two licenses for cultivation and manufacturing to be co-located with the current medical cultivation and manufacturing facility in Webster. The provisional licenses are for a new retail location in Provincetown, which is anticipated to be the first location on upper Cape Cod, and a new retail location in Ware. Curaleaf currently has medical retail locations in Hanover and Oxford.
Curaleaf employs 65 people in its national headquarters in Wakefield, MA and 80 people in its local Massachusetts operations. Over the past year, Curaleaf has grown to become one of the largest cannabis company in the United States under the leadership of CEO Joseph Lusardi, a Massachusetts native.
Disclaimer: Past performance is not an indicator of future performance.
Disclaimer: past performance is not an indicator of future performance.
About Curaleaf Holdings
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is the leading vertically integrated multi-state cannabis operator in the United States. It is a high-growth cannabis company with a national brand known for quality, trust and reliability. The company is positioned in highly populated, limited license states, and currently operates in 12 states with 49 dispensaries, 14 cultivation sites and 13 processing sites. Curaleaf has the executive expertise and research and development capabilities to provide leading service, selection, and accessibility across the medical and adult-use markets, as well as in the CBD category through its Curaleaf Hemp brand. On May 1, 2019, Curaleaf announced the acquisition of the Select brand from Cura Partners for approximately $949 million. On July 17, 2019, Curaleaf announced the acquisition of Grassroots for approximately $875 million.
& Keep Up to Date
Get the latest pot stock recommendations, cannabis news
and industry updates straight to your inbox!